HRMY - Harmony Biosciences Holdings - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HRMY is currently covered by 10 analysts with an average price target of $44.52. This is a potential upside of $15.09 (51.27%) from yesterday's end of day stock price of $29.43.

Harmony Biosciences Holdings's activity chart (see below) currently has 43 price targets and 95 ratings on display. The stock rating distribution of HRMY is 3.08% HOLD, 90.77% BUY and 6.15% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.05% with an average time for these price targets to be met of 89.55 days.

Highest price target for HRMY is $70, Lowest price target is $40, average price target is $47.8.

Most recent stock forecast was given by AMI FADIA from NEEDHAM on 10-Apr-2025. First documented stock forecast 11-Sep-2020.

Split History since 2000:

12/5/00 3 for 1

Currently out of the existing stock ratings of HRMY, 2 are a HOLD (3.08%), 59 are a BUY (90.77%), 4 are a SELL (6.15%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$50

$21.54 (75.69%)

$50

14 days ago
(10-Apr-2025)

3/28 (10.71%)

$21.01 (72.47%)

332

Buy

$70

$41.54 (145.96%)

$70

16 days ago
(08-Apr-2025)

0/7 (0%)

$41.87 (148.84%)

Buy

$44

$15.54 (54.60%)

$42

1 months 6 days ago
(18-Mar-2025)

9/22 (40.91%)

$9.22 (26.51%)

118

Buy

$55

$26.54 (93.25%)

$48

2 months 13 days ago
(11-Feb-2025)

0/2 (0%)

$17.26 (45.73%)

Buy

$61

$32.54 (114.34%)

$59

3 months 11 days ago
(13-Jan-2025)

1/7 (14.29%)

$24.55 (67.35%)

217

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HRMY (Harmony Biosciences Holdings) average time for price targets to be met?

On average it took 89.55 days on average for the stock forecasts to be realized with a an average price target met ratio 37.05

Which analyst has the current highest performing score on HRMY (Harmony Biosciences Holdings) with a proven track record?

AMI FADIA

Which analyst has the most public recommendations on HRMY (Harmony Biosciences Holdings)?

Ami Fadia works at NEEDHAM and has 7 price targets and 4 ratings on HRMY

Which analyst is the currently most bullish on HRMY (Harmony Biosciences Holdings)?

Patrick Trucchio with highest potential upside - $41.54

Which analyst is the currently most reserved on HRMY (Harmony Biosciences Holdings)?

Corinne Jenkins with lowest potential downside - -$0.46

Harmony Biosciences Holdings in the News

Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome

Data to be Presented at the Hot Topics in Child Neurology Podium Presentation Session at the American Academy of Neurology Annual Meeting PLYMOUTH MEETING, Pa., April 08, 2025–(BUSINESS WIRE)–Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced the presentation of updated data from its Open-Label Extension (OLE) study (ZYN2-CL-017) evaluating the safety and effectiveness of ZYN002...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?